## Diagnosis: Ornithine Transcarbamylase (OTC) Deficiency ### Clinical Presentation Analysis The key diagnostic clues are: - **Hyperammonemia** (180 µmol/L, normal <50 µmol/L) - **Markedly elevated urine orotic acid** — the pathognomonic finding for OTC deficiency - **Mild hypercitrullinemia** (not the dominant finding) - **Normal blood glucose** - **Consanguineous parents** (autosomal recessive inheritance — note: OTC is X-linked, but rare autosomal recessive forms exist; the stem specifies consanguinity) - **"Second enzyme of the urea cycle"** — OTC is the second enzyme in the urea cycle ### The Urea Cycle: Sequential Enzyme Order The urea cycle enzymes in order are: 1. **Carbamoyl phosphate synthetase I (CPS I)** — mitochondria; ammonia + CO₂ → carbamoyl phosphate 2. **Ornithine transcarbamylase (OTC)** — mitochondria; carbamoyl phosphate + ornithine → citrulline 3. **Argininosuccinate synthetase (ASS)** — cytosol; citrulline + aspartate → argininosuccinate 4. **Argininosuccinate lyase (ASL)** — cytosol; argininosuccinate → arginine + fumarate 5. **Arginase** — cytosol; arginine → urea + ornithine **OTC is the second enzyme** of the urea cycle (after CPS I). ### Why Elevated Orotic Acid + Mild Hypercitrullinemia? 1. **Orotic acid elevation (markedly elevated):** - When OTC is deficient, carbamoyl phosphate accumulates in the mitochondria and leaks into the cytosol - Excess cytosolic carbamoyl phosphate enters the pyrimidine synthesis pathway via carbamoyl phosphate synthetase II - This leads to overproduction of orotic acid → **markedly elevated urinary orotic acid** - This is the **pathognomonic finding** for OTC deficiency 2. **Mild hypercitrullinemia:** - Residual OTC activity produces small amounts of citrulline, explaining mild citrulline elevation - Citrulline levels are low-to-normal or mildly elevated (not markedly elevated as in ASS deficiency) 3. **Hyperammonemia:** - The urea cycle is blocked at OTC; ammonia cannot be incorporated into citrulline efficiently - Ammonia accumulates → encephalopathy, vomiting, poor feeding ### Why NOT Argininosuccinate Synthetase (ASS) Deficiency? - ASS deficiency (Citrullinemia Type I) is the **third** enzyme of the urea cycle, NOT the second - ASS deficiency causes **markedly elevated citrulline** (not just mild hypercitrullinemia) - The stem explicitly states "second enzyme of the urea cycle" — this is OTC, not ASS ### Differential Diagnosis of Urea Cycle Defects | Enzyme Deficiency | Order | Plasma Citrulline | Urine Orotic Acid | Key Feature | |---|---|---|---|---| | **OTC deficiency** | **2nd** | Normal/mildly ↑ | **↑↑↑ markedly elevated** | X-linked; orotic aciduria | | CPS I deficiency | 1st | Low/normal | Normal/low | No orotic aciduria | | ASS deficiency | 3rd | ↑↑↑ very high | ↑↑ elevated | Citrullinemia Type I | | ASL deficiency | 4th | ↑↑ high | ↑ mildly elevated | Argininosuccinic aciduria | | Arginase deficiency | 5th | ↑↑↑ | Normal | Spastic paraplegia | **High-Yield:** OTC deficiency = **2nd enzyme** of urea cycle = markedly elevated urinary orotic acid + hyperammonemia + normal/mildly elevated citrulline. ### Clinical Pearl **Key distinction:** OTC deficiency and CPS I deficiency both present with low/normal citrulline, but **OTC deficiency has markedly elevated orotic acid** while CPS I deficiency has normal/low orotic acid. The markedly elevated orotic acid in this case, combined with the "second enzyme" clue, confirms OTC deficiency. ### Management - Protein restriction - Sodium benzoate and sodium phenylbutyrate (nitrogen scavengers) - Arginine supplementation (to replenish the cycle) - Liver transplantation in severe cases *Reference: Harper's Illustrated Biochemistry, 31st ed.; Scriver's The Metabolic and Molecular Bases of Inherited Disease* 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.